Article -> Article Details

MARKET OVERVIEW

The Vietnam peripheral vascular devices market was valued at USD 49.20 Million in 2024 and is forecasted to reach USD 80.27 Million by 2033, growing at a CAGR of 5.59%. This growth is driven by increased cardiovascular disease prevalence, an aging population demanding advanced vascular care, technological advancements in minimally invasive procedures improving outcomes and recovery, and healthcare infrastructure development facilitating specialized vascular treatment access. 

STUDY ASSUMPTION YEARS

• Base Year: 2024
• Historical Year/Period: 2019-2024
• Forecast Year/Period: 2025-2033

VIETNAM PERIPHERAL VASCULAR DEVICES MARKET KEY TAKEAWAYS

• Current Market Size: USD 49.20 Million (2024)
• CAGR: 5.59%
• Forecast Period: 2025-2033
• Cardiovascular diseases account for 31% of total deaths in Vietnam, with over 170,000 deaths annually, significantly driving demand for peripheral vascular interventions.
• The aging demographic is increasing the need for advanced vascular care, especially to treat peripheral arterial disease, critical limb ischemia, and venous insufficiency.
• Technological innovations such as drug-eluting stents, advanced balloon angioplasty systems, atherectomy devices, and embolic protection devices are enhancing treatment effectiveness while minimizing patient trauma.
• Healthcare infrastructure improvements, including catheterization labs and specialized vascular centers, are expanding access to advanced peripheral vascular interventions across northern, central, and southern Vietnam.
• The market exhibits robust growth supported by government healthcare modernization programs and investments in cardiovascular care capabilities.

Sample Request Link: https://www.imarcgroup.com/vietnam-peripheral-vascular-devices-market/requestsample

MARKET GROWTH FACTORS

Vietnam's peripheral vascular devices market is significantly driven by the high prevalence of cardiovascular diseases. Cardiovascular conditions contribute to 31% of all deaths in the country, representing more than 170,000 deaths annually. This substantial disease burden is a primary factor boosting the demand for peripheral vascular interventions. Moreover, the increasing aging population necessitates advanced vascular care due to the complex nature of ailments such as peripheral arterial disease, critical limb ischemia, and venous insufficiency, which are more common in older patients. This demographic trend is compelling healthcare providers to increase investments in peripheral vascular technology and expand interventional capacity.

The market's expansion is further accelerated by continuous technological advancements in minimally invasive procedures. Healthcare providers across Vietnam are adopting next-generation devices that enhance precision, reduce procedural complexity, and improve patient safety compared to traditional surgery. Notable innovations include drug-eluting stents, advanced balloon angioplasty systems, atherectomy devices, and embolic protection technologies. These innovations allow more effective treatment of complex vascular conditions while minimizing trauma and shortening recovery times.

Government-driven healthcare infrastructure development is another critical growth enabler. Programs focusing on healthcare modernization facilitate the establishment of advanced catheterization laboratories, interventional suites, and specialized vascular centers equipped with the latest peripheral intervention technologies. This infrastructure expansion improves geographic access to peripheral vascular treatments, particularly across northern, central, and southern Vietnam, supporting higher procedure volumes, better outcomes, and broader adoption of advanced devices in the country's healthcare system.

MARKET SEGMENTATION

Device Type Insights:

• Peripheral Vascular Stents: Devices used to keep blood vessels open in peripheral vascular treatment.
• Peripheral Transluminal Angioplasty (PTA) Balloon Catheters: Balloons used during angioplasty to dilate narrowed peripheral arteries.
• Peripheral Transluminal Angioplasty (PTA) Guidewires: Guidewires aiding navigation through blood vessels during angioplasty.
• Atherectomy Devices: Equipment employed to remove plaque from blood vessels.
• Embolic Protection Devices: Devices designed to prevent embolic debris from traveling to other parts of the bloodstream during interventions.
• Inferior Vena Cava Filters: Implants to prevent blood clots from reaching the lungs.
• Others: Other peripheral vascular devices not classified in the above categories.

End User Insights:

• Hospitals and Clinics: Primary healthcare providers offering vascular intervention treatments.
• Ambulatory Care Centers: Outpatient facilities specializing in peripheral vascular care.
• Specialty Clinics: Clinics focused on specialized vascular treatments.
• Others: Additional healthcare settings using peripheral vascular devices.

Regional Insights:

• Northern Vietnam: Key regional market for peripheral vascular devices.
• Central Vietnam: Significant regional segment contributing to market growth.
• Southern Vietnam: Dominant regional market with substantial infrastructure and treatment access.

REGIONAL INSIGHTS

Southern Vietnam is the dominant regional market within the Vietnam peripheral vascular devices sector. Supported by the development of advanced healthcare infrastructure such as catheterization labs and vascular centers, Southern Vietnam facilitates broader geographic access to peripheral vascular interventions. This region along with Northern and Central Vietnam supports increasing procedural volumes and the adoption of advanced technologies, driving the market expansion through 2033.

RECENT DEVELOPMENTS & NEWS

Not provided in source.

KEY PLAYERS

• Not provided in source.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

ABOUT US

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

CONTACT US

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302